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Abstract.  For the extracellular (EC) domain of 
E-cadherin to function in homophilic adhesion it is 
thought that its intracytoplasmic (IC) domain must 
bind <~- and ~-catenins, which link it to the actin 
cytoskeleton. However, the IC domain of pemphigus 
vulgaris antigen (PVA  or Dsg3),  which is in the des- 
moglein subfamily of the cadherin gene superfamily, 
does not bind a- or/~-catenins. Because desmogleins 
have also been predicted to function in the cell adhe- 
sion of desmosomes, we speculated that the PVA IC 
domain might be able to act in a  novel way in confer- 
ring adhesive function on the EC domain of cadherins. 
To test this hypothesis we studied aggregation of 
mouse fibroblast L  cell clones that expressed chimeric 
cDNAs encoding the EC domain of E-cadherin with 
various IC domains. We show here that the full IC do- 
main of PVA as well as an IC subdomain containing 
only 40 amino acids of the PVA intracellular anchor 
(IA) region confer adhesive function on the E-cadherin 
EC domain without catenin-like associations with cy- 
toplasmic molecules or fractionation with the cell 
cytoskeleton. This IA region subdomain is evolution- 
arily conserved in desmogleins, but not classical 
cadherins. 
These findings suggest an important cell biologic 
function for the IA region of desmogleins and demon- 
strate that strong cytoplasmic interactions are not ab- 
solutely necessary for E-cadherin-mediated adhesion. 
T 
HE  originally described  or  classical  cadherins,  the 
prototypic example of which is E-cadherin, function 
as  homophilic,  calcium-dependent  adhesion  mole- 
cules (45, 46). These are widely distributed in epithelial as 
well as non-epithelial cells and are thought to be crucial in 
cell-cell adhesion and interactions in development thereby 
contributing to tissue architecture and formation. Their im- 
portance is also underscored by the correlation of their loss 
of function with metastatic potential of certain epithelial 
cancers (3, 47). 
Cadherins are integral membrane glycoproteins that have 
a transmembrane domain that spans the membrane once (4). 
The EC amino-terminal domain can be subdivided into four 
homologous subdomains and a fifth subdomain closest to the 
cell membrane. The intracytoplasmic (IC) ~ domain can be 
subdivided into an highly charged intracellular anchor (IA) 
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subdomain, just inside the cell, and a so-called IC cadherin 
segment (ICS) (see Fig.  1). 
The crucial function of the EC domain of cadherins in 
mediating calcium-dependent cell adhesion has been demon- 
strated by both antibody interference with function as well 
as by site-directed mutagenesis. For example, the monoclo- 
nal antibodies ECCD-1  and DECMA-1,  which are directed 
against the amino-terminal and carboxy-terminal extracellu- 
lar (EC) domain, respectively, block E-cadherin-mediated 
adhesion (33, 36). Mutagenesis of  one of  the calcium binding 
sites of E-cadherin abrogates its adhesive function (35).  Fi- 
nally, mutagenesis of the cleavage site of the precursor poly- 
peptide which prevents its proper processing to the mature 
form,  also  interferes with adhesive  function (37).  These 
mutagenesis studies suggest that proper EC conformation 
may be important for correct function. 
However, not only is the EC domain of cadherins crucial 
for proper function, but, perhaps surprisingly, so is their IC 
domain (29).  In fact, the IC domains of various classical 
cadherins are the most highly conserved domains within this 
family (10, 29).  These domains are known to bind cytoplas- 
mic molecules called catenins (34, 51). Co-precipitation ex- 
periments have demonstrated that cadherins bind to at least 
three molecules, c~-, ~-catenin and plakoglobin (19, 24, 34, 
40, 51). c~- and/3-catenins are thought to link the cadherins 
to the actin cytoskeleton (14, 27, 28, 34, 38).  This associa- 
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tion  of cadherins  associate  with  the  nonionic  detergent- 
insoluble cytoskeleton. Differential detergent extraction of 
cadherins has also shown that/~-catenin is most tightly bound 
to the IC domain of cadherins, and that t~-catenin  may pro- 
vide the link to the actin cytoskeleton (38). 
Various studies have demonstrated that the binding of the 
IC domain of cadherins to the catenins is correlated with the 
functional  ability  of the  EC  domain  (27,  28,  38).  Thus, 
cadherins  that  have  truncated  IC  domains  which  can  no 
longer bind the catenins, do not function to aggregate cells, 
even though the EC domain is expressed properly on the cell 
surface. Loss of as few as 37 amino acids from the carboxy 
terminus of the E-cadherin IC domain results in loss of the 
ability to bind catenins and mediate adhesion (27, 38). Simi- 
larly, cancer cells that have normal E-cadherin expression, 
but are genetically deficient in a-catenin expression, cannot 
aggregate (13, 42). Furthermore, expression of c~-catenin in 
these cells through cDNA transfection allows them to aggre- 
gate. Thus, in these cells even full-length E-cadherin does 
not inherently have the ability to mediate adhesion without 
interaction with catenins. 
These types of studies have led to a  generally accepted 
principle of cadherin function: cadherins must bind catenins 
inside the cell for them to function properly outside the cell. 
This intracellular binding is thought to confer adhesive func- 
tion  because  of linkage  of cadherins  to  the  cytoskeleton 
and/or  because  clustering  of the  cadherin  molecules  in- 
creases the avidity of their interactions. However, in spite of 
this dogma, there is some evidence that, in special situations, 
the EC domain of cadherins might retain some biological ac- 
tivity (9). For example, the EC domain of E-cadherin in one 
study (50), but not another (11), could interfere with E-cad- 
herin-mediated  cell-cell  adhesion.  The  EC  domain  of 
N-cadherin, when immobilized on a dish, can also demon- 
strate some biological activity in promoting retinal cell at- 
tachment and neurite outgrowth (39), but in this case the at- 
taching cells had intact N-cadherin presumably with proper 
cytoskeletal linkage. A chimeric molecule consisting of the 
EC  domain  of E-cadherin  (L-CAM)  and  the  transmem- 
brane/IC domain of N-CAM is able to function in adhesion, 
perhaps  because  the  N-CAM  IC  domain  binds  different 
cytoskeletal components than that of E-cadherin (16).  Fi- 
nally, T-cadherin, which is anchored to the membrane by a 
glycosyl phosphatidylinositol  group  and  thus  presumably 
does not bind the cytoskeleton through interaction with cate- 
nins, can mediate rather weak cell-cell adhesion (48). How- 
ever, the EC domain of T-cadherin lacks several properties 
of classical  cadherins  (i.e.,  E-cadherin,  N-cadherin,  and 
P-cadherin). 
Desmogleins form a subfamily of the cadherin supergene 
family (8, 20,  30, 49). Desmogleins and classical cadherins 
are homologous in amino acid sequence both in their EC do- 
mains as well as in the ICS of their IC domain. However, the 
desmogleins have a longer IC region than do classical cadhe- 
rins  (Fig.  1).  This  carboxy-terminal subdomain  contains 
a  desmoglein-specific repeating amino acid motif, and is, 
therefore, termed the intracellular repeat region. Whereas the 
classical cadherins localize to adherens junctions (which as- 
sociate  with  actin  microfilaments),  the  desmogleins  are 
found in desmosomes (into which insert keratin or other in- 
termediate filaments).  Two of the desmogleins,  Dsgl  and 
Dsg3,  are autoantigens in the autoimmune blistering  skin 
diseases  pemphigus  foliaceus  and  pemphigus  vulgaris, 
respectively (43). In fact, because Dsg3 was discovered as 
the target of autoantibodies in patients it is also termed PVA 
(2). These desmogleins have been shown to bind plakoglo- 
bin, but not t~- or fl-catenin, in epithelial cells (21, 40, 41). 
Although the function of desmogleins has not been clearly 
elucidated, they are speculated to function in cell adhesion 
because: (a) they are members of the cadherin gene super- 
family;  (b) autoantibodies against them cause loss of cell 
adhesion; (c) they localize to the desmosome, a cell adhesion 
structure. We speculated, therefore, that the IC domain of 
desmogleins might function in conferring adhesion without 
binding a- and ~-catenin and without interaction with the ac- 
tin cytoskeleton. To test this hypothesis we expressed cDNA 
encoding a chimeric molecule consisting of the EC domain 
of E-cadherin and the IC domain of PVA in L cells, mouse 
fibroblasts that contain et- and/~-catenin but no endogenous 
cadherins, and tested for adhesive function as well as cyto- 
plasmic and cytoskeletal interactions. 
Materials and Methods 
Construction of Chimeric cDNAs in Eukaryotic 
Expression Vectors 
/3-actin promoter-driven eukaryotic expression vectors with cDNA encod- 
ing  mouse  E-cadherin  (pBATEM2)  and  the  neomycin resistance gene 
(pBATneo)  were  kindly  provided by  Masatoshi Takeichi  (31).  EcadPV 
cDNA (see Fig. 1) was constructed by amplifying the EC domain of E-cad- 
herin by polymerase chain reaction (PCR) with primers containing EcoRV 
(5' primer) and Eco0109 (3' primer) restriction sites on their 5' ends. The 
transmembrane and IC domains of PVA were obtained by Eco0109 and Notl 
digestion of the previously cloned cDNA (2).  These products were cloned 
into the EcoRV/Not[ multiple cloning site of pcDNAl/Amp (Invitrogen 
Corp., San Diego, CA), a eukaryotic expression vector with a cytomegalo- 
virus (CMV) promoter. Dideoxy DNA sequencing revealed no PCR muta- 
tion in the EC domain of E-cadherin in this construct. 
EcadPVA320 cDNA (see Fig.  1) was constructed by PCR amplification 
of the EcadPV cDNA with the 5' primer at the 5' end of the cDNA and the 
3' primer  upstream of the  3' end  so  that  the  final  product  encoded a 
320-amino acid-truncated IC domain. This PCR product was subcloned 
into the CMV promoter-driven eukaryotic expression vector pcDNA3 (In- 
vitrogen). 
EcadA135  was  constructed as  previously  described (as  pBATEM24) 
(27). 
Transfection and Cloning of  L cells 
L  cells (CCL  1.1  American Type Tissue Culture  Collection, Rockville, 
MD) were grown in Dulbecco-modified Eagle's minimal essential medium/ 
Ham's 1=12 (GIBCO-BRL, Bethesda, MD), supplemented with 10%  fetal 
calf serum, in one-well tissue culture chamber slides (Nunc, Inc., Roskilde, 
Denmark). Transfection with 3 ~g EcadPV or EcadA135,  each with 0.3 p.g 
pBATneo or with 3/zg of EcadPVA320 and lipofectamine (GIBCO-BRL) 
was performed according to the manufacturer's directions. After 6 h, fresh 
medium was added. 48 h after transfection, cells were transferred to a I00 
mm dish and cultured in medium containing 400  #g/ml G418  (GIBCO- 
BRL).  After  12-14  d,  G418-resistant clones were isolated with cloning 
rings. Immunofluorescence  for cell surface expression of  the E-cadherin EC 
domain was used to determine which clones to further characterize. 
The Ecad clone used for these studies has been described previously (1). 
Immunofluorescence and Flow Cytometric Analysis 
of  L Cell Clones 
To detect the EC domain of E-cadherin on the surface of L cell clones we 
performed immunofluorescence on living cells with ECCD-2, a monoclo- 
nal anti-E-cadherin antibody kindly provided by Masatoshi Takeichi (Kyoto 
University, Kyoto, Japan), and an isotype-matched rat IgG2a (Pharmingen, 
San Diego, CA), as previously described (44). ECCD-2 was used as un- 
diluted hybridoma culture supernatant. A  1:100 dilution of a  1 mg/ml rat 
IgG2a (Pharmingen) was used as a negative control. A fluorescein-conju- 
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was used to detect these antibodies. 
We also used the same antibodies to estimate the amount of cell surface 
expression of the E-cadherin ectodomain by flow cytometric analysis of liv- 
ing cells, as previously described (1). In this case 5  x  105 cells in 200/~1 
were incubated with 10/~1 of ECCD-2 hybridoma culture supernatant or 
0.1 ~g of rat IgG2a isotype control. 
lmmunoprecipitation 
Immunoprecipitation of nonionic detergent extracts of radiolabeled L cell 
clones was performed essentially as described (1). Clones were radiolabeled 
for 4 h with [35S]methionine/cysteine  in methionine- and cysteine-free Dul- 
becco's modified Eagle's medium containing 5 % fetal calf serum. The su- 
pernatant  of the  detergent  lysate  was  collected after  centrifugation  at 
100,000 g for 30 min. Lysate containing 30 x  106 cpm per immunoprecip- 
Rate was first preabsorbed at 4"C with 25 #l of normal rat serum for 2 h, 
and then twice with 25 pl of protein G sepharose 4 fast flow (Pharmacia, 
Piscataway,  NJ) for 1-2 h each. The preabsorbed supernatant was immuno- 
precipitated with "~1-2 #g of ECCD-2 (purified from hybridoma culture su- 
pernatant with protein G) or rat IgG2a isotype control for 2 h, followed by 
25 #1 of protein G suspension for 1 h. Immunoprecipitates were washed five 
times with 0.5% Triton X-100 in TBS (150 mM NaCI in 10 mM Tris-HC1, 
pH  7.4),  then  eluted  with  sample  buffer  containing  dithiothreitol  and 
resolved on 6% tris-glycine SDS gels (Novex, San Diego, CA). 
Immunoblotting 
Transfected L cell clones were extracted with sample buffer containing di- 
thiothreitol. After incubation at 100*C for 2 rain, samples from equivalent 
cell numbers were electrophoresed on 8% tris-glycine SDS gels, and then 
electrophoretically transfered to nitrocellulose (Novex). Dr. Jackie Papkoff 
(Sugen, Inc., Redwood City, CA) kindly provided rabbit anti-mouse ~-cate- 
nin serum and rabbit anti-mouse plakoglobin serum (12), which were used 
for immunoblotting at 1:1,000 and 1:500, respectively, according to previ- 
ously reported procedures (2).  Antibodies were diluted in 5% powered 
milk in 0.05 % Tween-20 in TBS, and blots were washed with 0.05 % Tween- 
20 in TBS. The bound rabbit antibody was detected with a  1:500 dilution 
of alkaline phosphatase-conjugated goat anti-rabbit IgG (Tago),  and then 
developed (BCIP/NBT system; Bio-Rad Laboratories). 
Cell Aggregation Assays 
Single cell suspensions of L cell clones were obtained by incubation at 37°C 
for 20 rain with 0.01% trypsin (%8003; Sigma Chemical Co., St. Louis, 
MO)  in  10  mM  Hepes-buffered, calcium- and  magnesium-free Hanks 
balanced salt solution (HCMF; Biofluids Inc., Rockville, MD) with either 
1 mM CaCI2  (T/C condition; 0.01% trypsin in  1 mM CaCI2)  or  1 mM 
EDTA (T/E condition; 0.01% trypsin in 1 mM EDTA). Trypsin was neutral- 
ized  with  2  vol  HCMF  containing  0.05%  soybean  trypsin  inhibitor 
(GIBCO-BRL),  10%  fetal calf serum, and  10 ~g/ml DNAse I (GIBCO- 
BRL). Cells were washed with the same trypsin-neutralizing solution, and 
then dispersed into single cell suspension of 3  ×  105 cells per 3  ml of 
HCMF containing I% bovine serum albumin,  I0 #g/ml DNAse I, and 1 
mM CaCI2 or 1 mM EDTA. Each 3 ml of these cells was added to wells 
of six-well tissue culture plates (Falcon 3046; Becton Dickinson Labvrare, 
Mountain View, CA) which had been previously coated at 37°C for 2 h with 
2% bovine serum albumin in TBS. The cells were incubated on a rotary 
shaker (80 rpm) at 37°C for 20 min to  1 h, and then observed and pho- 
tographed and/or fixed by adding glntaraldehyde from a 70% stock solution 
(Polysciences Corp., Warrington, PAl to a final concentration of 2% before 
counting particles with a Coulter Counter (model ZB; Coulter Electronics, 
Hialeah,  FL).  The degree of aggregation was calculated by the formula 
(No -  Nro)/No) ×  100% where No and Nt,  o are the particle number at time 
0  and 60 min, respectively (27). 
To study inhibition of E-cadherin aggregation, ceils were aggregated in 
24-well plates (Costar Corp., Cambridge, MA) with a  1:100 dilution of 
ECCD-1 (53) or, as a control, PCD-I (32) ascites (from nude rat). Hybrid- 
omas producing both antibodies were kindly provided by M. Takeichi. 
Determination of  Fractionation of  Ecad and EcadPV 
with the Detergent-insoluble Cytoskeleton 
Nonionic detergent extracts of L cell clones (soluble fraction) and SDS ex- 
tracts of the resulting pellet (insoluble fraction) were subjected to immuno- 
blotting as previously described (27)  with the following minor modifica- 
tions. 3  x  106 cells were extracted with 100/~1 of 2.5%  Nonidet P-40 in 
HCMF to obtain the soluble fractions. The insoluble pellet was extracted 
with 200 ttl of 1x SDS gel sample buffer (Novex). Immunobloning was per- 
formed as described above except that membranes were blocked with 3 % 
gelatin in TBS and stained with a 1:25 dilution in 0.1% Tween-20 of a 35× 
concentrated ECCD-2 hybridoma supernatant. ECCD-2 was detected with 
alkaline phosphatase-conjugated goat anti-rat IgG (Tago). 
Computer A nalysis 
The GAP and PileUp program from the University of Wisconsin Genetics 
Computer Group software (7) on a VAX computer were used to determine 
homologies among desmogleins and cadherins. 
Results and Discussion 
Cloning of L Cells Expressing the EC Domain of 
E-Cadherin Together with Various  IC Domains 
Eukaryotic expression vectors were constructed with eDNA 
encoding the EC domain of E-cadherin and either the com- 
plete or truncated E-cadherin IC region or the complete or 
truncated  IC  region  of PVA  (Dsg3).  These  vectors  were 
transfected, along with a neomycin resistance gene, into L 
cells, mouse fibroblasts that do not normally express cadhe- 
rins.  L cell clones stably expressing these constructs were 
selected in G418-containing growth medium. 
The proteins encoded by these constructs are shown in 
Fig. 1. Clones expressing full-length E-cadherin (Ecad) were 
used as a positive control for calcium-dependent cell aggre- 
gation assays (26). Clones expressing E-cadherin minus the 
carboxy-terminal  135  amino acids  (EcadA135)  were  used 
as negative controls for each aggregation assay to rule out 
non-specific aggregation. It is known that this truncated mol- 
ecule does not bind catenins, does not organize with the actin 
cytoskeleton, and does not mediate calcium-dependent ag- 
gregation (27). Although we arbitrarily chose EcadA135 as 
a functional negative control for our adhesion assay, it should 
be noted that truncations of the E-cadherin carboxy terminus 
as small as 50 or 37 residues have been reported by three 
different research groups to also cause complete loss of the 
ability of E-cadherin to mediate aggregation in this system 
(16,  27,  38). 
Clones expressing chimeric molecules containing the EC 
domain of E-cadherin and the transmembrane and IC do- 
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Figure  1.  Proteins  expressed by  L  cell  clones  transfected  with 
cDNAs.  EC,  extraceUular  domain  of E-cadherin;  T,  transmem- 
brahe  region;  IA,  intracellular  anchor;  ICS,  intracytoplasmic 
cadherin segment; IPL,  intracytoplasmic proline-rich linker; 1R, 
intracytoplasmic  (desmoglein) repeating unit.  PV,  region of chi- 
meric EcadPV molecule from PVA; Ecad, region from E-cadherin. 
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main of PVA could substitute for that of E-cadherin in con- 
ferring adhesive function on the EC domain of E-cadherin. 
Finally,  clones  expressing  EcadPV  minus  the  carboxy- 
terminal 320 amino acids (EcadPVA320) were used to deter- 
mine which subdomains of the IC region of PVA might be 
important in conferring function on the EC domain of E-cad- 
herin. 
Detection of CeU Surface Expression of the 
Ectodomain of E-Cadherin  on Ecad, EcadPV, 
and EcadA135 Clones 
L  cell clones described above were first screened by im- 
munofluorescence with ECCD-2, a monoclonal anti-E-cad- 
herin antibody. Clones with positive cell surface expression 
were selected for further study. There was no clear cut differ- 
ence in the pattern of immunofluorescence staining between 
Ecad and EcadPV clones (Fig. 2, A and B). E-cadherin, in 
both cases, tended to be concentrated at cell-cell borders, 
but  was  also  seen on the  free surface of cells.  However, 
EcadA135 clearly showed a different pattern with more dif- 
fuse cell surface staining and more rounded cells (Fig. 2 C). 
Control neomycin-transfected L  cells (neofl) did not show 
any staining with ECCD-2 (Fig. 2 D). 
For aggregation studies we wanted to use clones that ex- 
pressed about similar amounts of the ectodomain of E-cad- 
herin on their cell surface. Therefore, we used flow cytomet- 
ric analysis to roughly quantitate and compare clones for cell 
surface expression of the EC domain of E-cadherin. Flow 
cytometric analysis was done at the same time as aggregation 
studies because, interestingly, we noted that with increasing 
time in culture EcadPV clones tended to display lower cell 
surface expression of the E-cadherin ectodomain (whereas 
Ecad clones had  stable  expression).  Fig.  3  A  shows  that 
Ecad, EcadA135, and EcadPV clones had comparable sur- 
face expression of the E-cadherin ectodomain. These are the 
same clones used for aggregation in Fig.  5 A (see below). 
The EcadPV Chimeric Molecule Does Not Show IIght 
Association with ~- or (3-Catenins in L Cells 
Full length desmogleins, including PVA, do not bind a- or 
/$-catenins  in epithelial cells (40, 41). We wanted to rule out 
the possibility  that  the  chimeric EcadPV  molecule binds 
these catenins in these L cell clones. ECCD-2 was used to 
precipitate EcadPV and Ecad from metabolically radiola- 
beled  proteins  extracted  with  nonionic  detergent  from 
the corresponding L cell clones (Fig. 4). As expected, ~- and 
~-catenin were co-precipitated with Ecad. However, with the 
same  conditions,  these  catenins  were  not  co-precipitated 
with EcadPV.  Two independently isolated EcadPV clones 
were immunoprecipitated with the same result. 
In keratinocytes and other epithelial cells the IC domain 
of PVA binds plakoglobin (21). Since fibroblasts may contain 
small amounts of plakoglobin (5,  17),  we wanted to deter- 
Figure 2. Immunofluorescence  of L cell clones with anti-E-cadherin antibody, ECCD-2. (A) Ecad clone. (B) EcadPV clone. (C) EcadA135 
clone. (D) neo/3 clone. Bar, 100/zm. 
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Figure 3.  Flow cytometric analysis of L cell clones stained with 
ECCD-2. 
mine if our chimeric EcadPV molecule bound plakoglobin 
in these L cells. Although, as shown in Fig. 4, we did not 
usually  detect  plakoglobin  co-precipitated  with  EcadPV, 
with long exposures of these gels there was a faint band in 
the molecular weight range of plakoglobin, suggesting that 
there may be a small amount of plakoglobin in these cells or 
that its association with EcadPV is weak. 
All  the  above  data  indicated  that  we  had  established 
EcadPV clones that expressed the EC domain of E-cadherin 
in about the  same  amounts  as  Ecad clones,  but that,  un- 
like Ecad, the EcadPV chimeric molecule did not bind ~- 
or/3-catenins and, with the possible exception of slight pla- 
koglobin binding,  did not show a  strong association with 
other cytoplasmic molecules in these cells. We could then 
ask the question whether EcadPV could mediate aggregation 
of these cells as does full-length, authentic, E-cadherin. In 
other words we could test the generally accepted dogma that 
E-cadherin must bind cytoplasmic ~- and/~-catenins and/or 
the cytoskeleton to function in adhesion. 
Figure 4. Immunoprecipitation of nonionic detergent extracts of L 
cell clones. EcadPV and Ecad indicate that extracts of these L cell 
clones were precipitated.  C refers to a neo/~ control clone, uE, 
ECCD-2; R/g, rat antibody isotype control. Arrow shows EcadPV 
chimeric molecule. Note that c~- and #-catenin are not co-precipi- 
tated with EcadPV, but are with Ecad (indicated by dot). 
EcadPV L Cell Clones Aggregate with the Same 
Properties as Do Ecad Clones 
To test aggregation, we made single cell suspension of L cell 
clones with T/C and let cells aggregate with gentle swirling 
at 37°C for 20-60 min in the presence or absence of 1 mM 
calcium, as previously described (26). Fig. 5 A shows that, 
as expected (because cadherin aggregation is calcium depen- 
dent), the Ecad clone aggregated well in the presence, but 
not in the absence of calcium, whereas the neo~ clone, with- 
out any cadherin expressed, did not aggregate under either 
condition. Also, as previously reported (27), the EcadA135 
clone did not aggregate either with or without added calcium 
(Fig. 5 A). However, the EcadPV clone aggregated strikingly 
with, but not without, calcium (Fig. 5 A). As with the Ecad 
clone, the EcadPV clone showed such marked aggregation 
that it could be seen grossly as large clumps in the tissue cul- 
ture dish. Aggregation can be semi-quantitated by counting 
number of particles before and after aggregation. Ecad and 
EcadPV clones showed 86 and  72%  aggregation,  respec- 
tively, whereas neo/~ and  EcadA135 showed less than 2% 
aggregation. The aggregation assays shown in Fig. 5 A were 
performed  simultaneously  with,  and  correspond  to,  the 
flow cytometric data in Fig. 3 A. In addition, four different 
EcadPV clones showed similar striking aggregation. 
To  further  show  that  EcadPV  aggregation  was  indeed 
cadherin mediated we wanted to show that it would not take 
place after cells were harvested with T/E. A well-established 
Roh and Stanley E-Cadherin Adhesion by Dsg3 Cytoplasmic Domain  943 Figure 5. Aggregation assays of L cell clones.  (.4) Ecad and Ecad 
PV show calcium-dependent aggregation, whereas neo/3 and Ecad- 
A135 do not. (B) EcadPV aggregation is destroyed by T/E, but not 
T/C, and is inhibited by ECCD-I, but not control antibody PCD-1. 
(C) EcadPVA320 shows calcium-dependent aggregation to the same 
degree as EcadPV. EcadA135 shows no aggregation. Bar, 150 #m. 
The Journal of Cell Biology, Volume 128, 1995  944 property of the EC domain of E-cadherin is that it is resistant 
to degradation by T/C, independent of whether its IC domain 
binds catenins, but sensitive to degradation by T/E (6, 15, 27, 
45, 52). Fig. 5 B shows that EcadPV cells only aggregate af- 
ter T/C, but not T/E, incubation. 
Finally, we showed that the aggregation of EcadPV cells, 
like Ecad cells, was inhibited by ECCD-1, a monoclonal anti- 
body known to block E-cadherin function (53), but not by 
the irrelevant monoclonal antibody PCD-1,  against  P-cad- 
herin (32) (Fig. 5 B). 
Unlike Ecad, EcadPV Does Not Partition with the 
Cytoskeletal Fraction of  L Cells 
It is  thought that one reason E-cadherin must bind to a- 
and f3-catenins  in  order to function is  that these catenins 
might provide a linkage to the actin cytoskeleton (27,  34). 
This  linkage  of E-cadherin to  the  cytoskeleton has  been 
classically  assayed  in  L  cell  transfectants  by  extracting 
the cells with nonionic detergent, then subjecting the sol- 
uble and insoluble (cytoskeletal) fraction to immunoblotting 
for E-cadherin (25, 27, 34). In this assay, binding of eatenins 
by E-cadherin correlates with partition of a fraction of the 
E-cadherin with the detergent insoluble cytoskeleton. On the 
other hand, E-cadherin that is truncated in its IC domain and 
no longer binds  catenins,  no longer fractionates with the 
cytoskeleton. Therefore, it has been speculated that catenins 
confer adhesive function on E-cadherin by providing binding 
to the cytoskeleton. 
This speculation suggests that one reason EcadPV might 
function in adhesion is that the PVA IC domain might inter- 
act directly with the cytoskeleton. To test this possibility, we 
assayed EcadPV and Ecad L cell clones with the standard 
assay described above (Fig. 6). The nonionic detergent solu- 
ble and insoluble fractions were subjected to immunoblot- 
ting with ECCD-2. We used the Ecad L cell clone as a posi- 
tive control in this assay to confirm that a  fraction of the 
E-cadherin did partition with the nonionic detergent insolu- 
ble cytoskeleton. In contrast, unlike E-cadherin,  EcadPV 
was totally soluble with nonionic detergent, and none was 
detected in the cytoskeletal fraction. Therefore, we conclude 
that EcadPV does not show the same type linkage to the 
cytoskeleton as does E-cadherin. 
Only the IA Subdomain of  PVA, Which Is Highly 
Conserved in Desmogleins, Is Necessary to Confer 
Function on the EC Domain of E-Cadherin 
We next wanted to determine if the ICS subdomain PVA is 
necessary to confer function on the EC region of  E-cadherin. 
The ICS subdomain of Dsgl  (23) as well as PVA (unpub- 
lished  observation)  is  necessary for plakoglobin binding, 
therefore, this  subdomain would be necessary for activat- 
ing the EC domain of E-cadherin if a small amount of plako- 
globin binding with EcadPV is important. The ICS region 
of PVA and human E-cadherin also share 44%  homology 
and, therefore, this cadherin-like segment might substitute in 
some other way for that of authentic E-cadherin in conferring 
function. We, therefore, created the cDNA construct encod- 
ing EcadPVA320, which deletes the entire PVA IC domain 
except for about half of the IA region (Fig.  1). Surprisingly, 
L  cell clones expressing this construct (Fig.  3 B) showed 
striking calcium-dependent aggregation to the same degree 
as EcadPV transfected clones (Fig. 5 C), both about 80%. 
In  addition,  immunoprecipitation  of  EcadPVA320  from 
these clones showed no co-precipitated molecules, even after 
long exposure of the gels. 
Another way  of determining  if the IC  region of Ecad- 
PVA320 interacts with catenins is to determine their steady- 
state levels in these clones, because it has been suggested that 
plakoglobin and/3-catenin are stabilized in cells by their in- 
teractions with the IC domain of cadherins (12,  22).  We, 
therefore, determined  steady-state levels of/~-catenin and 
plakoglobin by immunoblotting extracts of Ecad, EcadA135, 
and EcadPVA320 clones (Fig. 7).  Both molecules were at 
much higher levels in Ecad cells, than in either EcadA135 
Figure 6.  Fractionation of Ecad 
and  EcadPV  with  the  nonionic 
detergent soluble (S) and insolu- 
ble (I) fractions of L cell clones. 
Part of Ecad fractionates with the 
insoluble fraction, but EcadPV is 
completely extracted in the solu- 
ble  fraction,  suggesting it  does 
not  associate  strongly  with  the 
nonionic detergent-insoluble cy- 
toskeleton. 
Figure 7. Immunoblots of/$-catenin ((3-caO  and plakoglobin (plak) 
in extracts of  Ecad, EcadPVA320, and EcadA135 clones. Arrow in- 
dicates ~-catenin, arrowhead indicates plakoglobin. Other bands in 
the plakoglobin immunoblot are not identified, but the band just be- 
low plakoglobin may be a breakdown product. Note that/3-catenin 
and plakoglobin are stabilized only in the Ecad clones. Std indicates 
molecular weight standards (205, t16, 80, 49 kD). 
Roh and Stanley  E-Cadherin Adhesion by Dsg3 Cytoplasmic  Domain  945 Figure 8.  Amino acid homol- 
ogies among the IA regions of 
Dsgl,  Dsg2, and  Dsg3 (A), 
and between these regions of 
Dsg3 and E-cadherin (B). (A) 
Dsgl,  Dsg2, and Dsg3 show 
marked  homology. Shading 
indicates identical amino acids 
between  at  least  two  of the 
desmogleins. Asterisk (*) in- 
dicates the three desmogleins have identical or chemically homologous amino acids at that position. Amino acids to the right (carboxy- 
terminal) of the vertical arrow were truncated in the EcadPV&320  construct. Note that the major homology in the IA region was preserved 
in EcadPVA320. (B) As illustrated by Dsg3 and E-cadherin (Ecad), desmogleins and classical cadherins show little homology in the IA 
region for several reasons: (a) the IA region of cadherins is much shorter than that of desmogleins; (b) there are few identical amino acids 
when the IA regions are aligned (shaded); (c) classical cadherins lack cysteines (reverse font) in this subdomain; (d) Cadherins have posi- 
tively charged amino acids (boxed) just inside the membrane, whereas desmogleins have cysteines in conserved locations in this area. 
or EcadPV&320 cells, demonstrating that the IC domains of 
these later two cell types do not stabilize/$-catenin or plako- 
globin. This data is consistent with the immunoprecipitation 
data which show little,  if any,  interaction of EcadPVA320 
with catenins or plakoglobin. 
These results show that a minimum of 40 amino acids of 
the IA region of PVA are sufficient to confer function on the 
EC region of E-cadherin, therefore, suggesting a potentially 
important function for this region of the IC domain of PVA. 
The IA region of E-cadherin does not fulfill this function be- 
cause truncated constructs of E-cadherin containing the en- 
tire IA region do not mediate aggregation (16, 27,  38).  In 
fact, removal of only 37 residues from the carboxy terminus 
of E-cadherin results in complete loss of function (27, 38). 
If there is an important cell biologic function in the IA re- 
gion of PVA, it might be expected to be conserved in amino 
acid sequence among desmogleins. On the other hand, since 
it presumably does not fulfill this function in classical cadhe- 
rins it would not be expected to be conserved between des- 
mogleins and classical cadherins.  This is indeed the case. 
Fig. 8 A shows a high degree of amino acid homology in the 
IA subdomains of Dsgl, Dsg2, and Dsg3, especially in the 
40  amino  acids  preserved  in  EcadPVA320.  There  is  no 
significant  homology  between  this  subdomain  of  des- 
mogleins and that of E-cadherin (Fig.  8 B). 
We tried to determine if we could eliminate 26 of these re- 
maining 40 amino acids from the IA subdomain by making 
an EcadPVA346 construct, but clones derived expressing 
this construct were very unstable, and even in the initially 
isolated clones they were heterogeneous for cell surface ex- 
pression of the E-cadherin ectodomain. 
In conclusion, then, using the same methods previously 
shown to demonstrate c~- and B-catenin binding and cyto- 
skeletal association of classical cadherins, we show here that 
neither property is detectable in an EcadPV or EcadPVA320 
chimeric molecule, yet these molecules function in cell-cell 
aggregation. We conclude that E-cadherin is able to function 
in adhesion without tight ct- or B-catenin and/or cytoskeletal 
association. Since the PVA IC region has been shown to bind 
to plakoglobin, it could be argued that this cytoplasmic inter- 
action might activate the EC domain of E-cadherin.  How- 
ever, little plakoglobin is co-precipitated with EcadPV and 
none is detectable in co-precipitates of EcadPVA320. In ad- 
dition,  steady-state  plakoglobin  levels  are  stabilized  by 
E-cadherin (presumably by association of plakoglobin with 
the E-cadherin IC domain), but not by EcadPVA320. Finally, 
the EcadPVA320 construct does not contain the ICS region 
known to be critical for plakoglobin binding by desmogleins. 
These data suggest an important function for the highly 
conserved IA cytoplasmic subdomain of desmogleins.  We 
speculate that the most likely function of this region might 
be to  cluster the molecules in  the membrane.  Clustering 
might be an important factor in increasing the efficiency of 
E-cadherin aggregation,  as has previously been suggested 
(18). For desmoglein function, clustering might be an impor- 
tant factor in desmosome formation. In any case, the obser- 
vations presented here suggest that future studies focusing on 
the IA region of desmogleins are likely to demonstrate im- 
portant cell biologic functions. 
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